Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia
- 1 October 2014
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 85, 440-450
Abstract
No abstract availableKeywords
Funding Information
- Addex Pharmaceuticals (RF-2010-2311657)
- Ministero Salute
- Dystonia Medical Research Foundation
This publication has 54 references indexed in Scilit:
- Phenomenology and classification of dystonia: A consensus updateMovement Disorders, 2013
- Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptorsFrontiers in Molecular Neuroscience, 2011
- An integrated view on the role of receptor mosaics at perisynaptic level: focus on adenosine A2A, dopamine D2, cannabinoid CB1, and metabotropic glutamate mGlu5receptorsJournal of Receptors and Signal Transduction, 2010
- Abnormal striatal and thalamic dopamine neurotransmissionNeurology, 2009
- Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher‐order oligomers in living cellsJournal of Neurochemistry, 2009
- The pathophysiological basis of dystoniasNature Reviews Neuroscience, 2008
- The Akt–GSK-3 signaling cascade in the actions of dopamineTrends in Pharmacological Sciences, 2007
- Excitatory effects of serotonin on rat striatal cholinergic interneuronesThe Journal of Physiology, 2005
- Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneuronsNeuropharmacology, 2005
- Functional and molecular characterization of metabotropic glutamate receptors expressed in rat striatal cholinergic interneuronesJournal of Neurochemistry, 2002